Stockscreener 앱 받기
45.66
1.19%
-0.55
시간 외 거래:
45.70
0.04
+0.09%
Tarsus Pharmaceuticals Inc 주식(TARS)의 최신 뉴스
Tarsus Pharmaceuticals appoints new Chief Medical Officer - Investing.com
Papulopustular Rosacea Market to Expand Significantly by 2034, States DelveInsight Report | Sol-Gel Technologies, Galderma, CollaGenex Pharma, Tarsus Pharma, Pfizer - Barchart
Tarsus Appoints Elizabeth Yeu, M.D., as Chief Medical Officer - GlobeNewswire
Here's Why Tarsus Pharmaceuticals (NASDAQ:TARS) Can Manage Its Debt Despite Losing Money - Simply Wall St
Vanguard Group Inc's Strategic Acquisition in Tarsus Pharmaceuti - GuruFocus.com
Emerald Mutual Fund Advisers Trust Acquires New Position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
Tarsus Pharmaceuticals (NASDAQ:TARS) Trading 8.5% HigherShould You Buy? - MarketBeat
Tarsus Pharmaceuticals (TARS) Surges 10.6%: Is This an Indication of Further Gains? - MSN
Tarsus Pharmaceuticals stock hits 52-week high at $42.63 By Investing.com - Investing.com Australia
Tarsus Pharmaceuticals (NASDAQ:TARS) Sets New 52-Week HighShould You Buy? - MarketBeat
Tarsus Pharmaceuticals stock hits 52-week high at $42.63 - Investing.com
Tarsus Pharmaceuticals (NASDAQ:TARS) Shares Gap UpHere's Why - MarketBeat
Allspring Global Investments Holdings LLC Buys 29,465 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat
Assenagon Asset Management S.A. Raises Stock Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat
Tarsus Launches “Your Mitey Problem,” the First Direct-to-Consumer TV Campaign for XDEMVY - The Bakersfield Californian
Tarsus Launches “Your Mitey Problem,” the First - GlobeNewswire
Tarsus Pharmaceuticals, Inc Announces the Launch of New Direct-To-Consumer TV campaign for XDEMVY - Marketscreener.com
Essex Investment Management Co. LLC Invests $3.59 Million in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat
Was Tarsus Pharmaceuticals Inc (TARS)’s session last reading good? - US Post News
Financial Analysis: Tarsus Pharmaceuticals Inc (TARS)’s Ratios Unveil Key Insights - The Dwinnex
Taking a look at what insiders are doing to gauge the Tarsus Pharmaceuticals Inc (TARS)’s direction - Knox Daily
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives $51.60 Consensus Price Target from Analysts - MarketBeat
Tarsus Pharmaceuticals Inc (TARS) Q2 2024 Earnings Call Highlights: Robust Sales Growth and ... - Yahoo Finance
Papulopustular Rosacea Market Revenue to Expand Significantly - openPR
Tarsus Pharmaceuticals, Inc.'s (NASDAQ:TARS) Path To Profitability - Simply Wall St
Millennium Management LLC Raises Position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat
Recent Insider Activity Suggests Potential Gains for Tarsus Pharmaceuticals Inc (TARS) - Knox Daily
Dimensional Fund Advisors LP Sells 17,931 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat
Healthcare of Ontario Pension Plan Trust Fund Decreases Stake in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat
Tarsus Pharmaceuticals (NASDAQ:TARS) versus Genocea Biosciences (NASDAQ:GNCA) Critical Contrast - Defense World
Tarsus Pharmaceuticals (NASDAQ:TARS) Shares Up 5.3%Here's Why - MarketBeat
(TARS) On The My Stocks Page - Stock Traders Daily
Scientech Research LLC Invests $289,000 in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Tarsus Pharmaceuticals' SWOT analysis: stock surges on XDEMVY success - Investing.com
Tarsus Pharmaceuticals' SWOT analysis: stock surges on XDEMVY success By Investing.com - Investing.com South Africa
Taking the lead: Tarsus Pharmaceuticals Inc (TARS) - SETE News
Driehaus Capital Management LLC Purchases 203,300 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat
Frazier Life Sciences Management L.P. Reduces Stock Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat
Tarsus Pharmaceuticals Inc [TARS] Records 200-Day SMA of $29.59 - Knox Daily
How did Tarsus Pharmaceuticals Inc (TARS) fare last session? - US Post News
Tarsus to Participate in Fireside Chat at UBS Virtual Ophthalmology Day 2024 - ForexTV.com
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Holdings Decreased by Ensign Peak Advisors Inc - MarketBeat
Tarsus Pharma maintains stock target on ECP feedback - Investing.com
Federated Hermes Inc. Acquires 11,018 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Rhumbline Advisers Acquires 6,070 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Tarsus Pharmaceuticals: Unlocking Growth Potential With Eye Care Innovations (NASDAQ:TARS) - Seeking Alpha
Midday Stock Roundup: Staar Surgical Up - Orange County Business Journal
Tarsus Pharmaceuticals Inc [TARS] Shares Jump Approximately 103.53% Over the Year - Knox Daily
Tarsus Pharmaceuticals Inc (TARS) expanding its growth trajectory ahead - SETE News
Trane Technologies (NYSE:TT) Sets New 52-Week High at $382.49 - MarketBeat
Taking a look at what insiders are doing to gauge the Trane Technologies plc (TT)’s direction - Knox Daily
Closing Figures Unveiled: Traws Pharma Inc. (TRAW) Drop -10.26, Closes at 0.31 - The Dwinnex
Traws Pharma Inc. (TRAW) Stock: A Comprehensive 52-Week Review - The InvestChronicle
2024Risk of supply problem | Theratechnologies issues warning, shares lose 15% - Actual News Magazine
Tarsus Pharmaceuticals (NASDAQ:TARS) Trading Up 3.6% - MarketBeat
2.02%
0.47%
자본화:
|
볼륨(24시간):